World Enzymes

Summary

Global demand to rise 7.6% annually through 2011

The world market for enzymes will grow 7.6 percent per year to $6 billion in 2011, driven by continued robust growth in pharmaceutical enzyme demand, doubledigit increases in demand for biocatalysts for pharmaceutical and other fine chemical production, as well as the rapid expansion in bioethanol production from grains.

Specialty enzyme markets offer good opportunities Despite recent uncertainty in the important US pharmaceutical market, world pharmaceutical enzyme demand will experience rapid advances going forward. As was the case over the past decade, the primary growth drivers will be rapid gains in both botulinum toxin-based neuromodulator and enzyme replacement therapy (ERT) drugs, which will offset slower growth in digestive enzymes and thrombolytics. The importance of biologically-derived chemicals will also be apparent in the biocatalysts market as chemical and pharmaceutical companies increasingly utilize these powerful enzymes to replace expensive precious metal-based catalysts as they optimize specialty and fine chemical production.

Outside the specialty enzyme segment, US concern about that country's dependence on foreign oil will lead to extraordinary increases in federally mandated use of grain-based ethanol in the gasoline pool, which will in turn drive enzyme demand. Outside of North America, global warming concerns will play a greater role in boosting grain ethanol production in Europe and parts of the Asia/Pacific. However, despite significant investments in research and development, biomass-based ethanol production will not meaningfully contribute to enzyme demand until the longer term.

Asia/Pacific region to offer best industrial enzyme gains Growing market maturity in North America and Europe, as well as potentially devastating avian and pork diseases in the Asia/Pacific region, will moderate advances in animal feed enzyme demand to near the global enzyme demand average. Similarly, food and beverage enzyme demand will also moderate to near the global average, though new applications and rapid expansion in the Asia/Pacific region will ensure growth remains strong. Among other markets, gains will be healthy in diagnostics, and research and biotechnology, while the maturity of cleaning products, and textiles and leather, results in slower advances. On a regional basis, the fastest growth will be in the Asia/Pacific and other developing regions as rising per capita incomes lead to more intensive use of enzymes, with North America and Western Europe trailing behind.

Study coverage

This new Freedonia industry study, World Enzymes, is priced at $5400. It presents historical demand data (1996, 2001 and 2006) plus forecasts for 2011 and 2016 by enzyme market, product, world region and for 43 countries. The study also considers global market environment factors, evaluates company market share data and profiles 43 competitors worldwide.

Content